Edward Dul
Impact in
- Molecular Biology top 5%
- Bone Metabolism and Diseases
- Cell death mechanisms and regulation
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- Immunology top 10%
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 4
- PI3K/AKT/mTOR signaling in cancer 3
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Bone Metabolism and Diseases 2
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Edward R. Appelbaum (5 shared papers)Ian E. James (2 shared papers)Robert A. Dodds (2 shared papers)John G. Emery (1 shared paper)Sally D. Lyn (1 shared paper)Peter R. Young (1 shared paper)Martin J. Rosenberg (1 shared paper)Peter McDonnell (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Journal of Biological Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Leukocyte Biology (1 paper)Calcified Tissue International (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Edward Dul
14 papers receiving 2.5k citations
Edward Dul's Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.9k
- Immunology 467
- Cancer Research 304
- Oncology 553
- Immunology and Allergy 93
Countries citing papers authored by Edward Dul
This map shows the geographic impact of Edward Dul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Dul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Dul more than expected).
Fields of papers citing papers by Edward Dul
This network shows the impact of papers produced by Edward Dul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Dul. The network helps show where Edward Dul may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Dul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL Hit paper breakdown → | 1998 | 1034 |
| 2 | 2012 | 396 | |
| 3 | 2003 | 312 | |
| 4 | 1995 | 153 | |
| 5 | 1997 | 143 | |
| 6 | 2006 | 142 | |
| 7 | 2006 | 138 | |
| 8 | 1995 | 89 | |
| 9 | 2006 | 69 | |
| 10 | 2008 | 66 | |
| 11 | 2014 | 37 | |
| 12 | 2013 | 20 | |
| 13 | 2004 | 17 | |
| 14 | 1997 | 17 |
About Edward Dul
Edward Dul is a scholar working on Molecular Biology, Oncology, Rheumatology, Immunology and Orthodontics, having authored 14 papers that have together received 2.6k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer-related gene regulation (2 papers), Epigenetics and DNA Methylation (2 papers), Peptidase Inhibition and Analysis (2 papers), RNA modifications and cancer (2 papers), Bone and Dental Protein Studies (2 papers) and Bone Metabolism and Diseases (2 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Immunology (467 citations), Cancer Research (304 citations), Oncology (553 citations) and Immunology and Allergy (93 citations). Edward Dul has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Edward R. Appelbaum, Ian E. James, Robert A. Dodds, John G. Emery, Sally D. Lyn, Peter R. Young, Martin J. Rosenberg, Peter McDonnell, Carol Silverman and Keith C. Deen. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics, Journal of Leukocyte Biology and Calcified Tissue International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.